Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA

Lancet Infect Dis. 2024 May;24(5):e278-e280. doi: 10.1016/S1473-3099(24)00150-6. Epub 2024 Mar 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • Humans
  • SARS-CoV-2* / immunology
  • United States / epidemiology
  • Vaccine Efficacy

Substances

  • Antiviral Agents
  • COVID-19 Vaccines

Supplementary concepts

  • SARS-CoV-2 variants